Thesla Palanee‐Phillips

Author

Also Known As

Baeten, Jared M., Barnabas, Ruanne V., Batting, Joanne, Gonasagrie Nair, Hobbs, Marcia, Jared Baeten, Jared M. Baeten, K. Woeber, Kerusha Padayachee, L. Danielle Wagner

209

Publications

6.9K

Citations

H-Index

Concepts

All Affiliations

University of Washington University of the Witwatersrand South African Medical Research Council Family Health International 360 Fred Hutch Cancer Center

About

Thesla Palanee‐Phillips is an author at University of Washington specializing in sexual health, medicine, and hiv.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	12	13	1.7K
2	Public Health	10	10	872
3	Health Sciences	2	2	59
4	Education	1	1	24
5	Nursing	1	1	16

Thesla Palanee‐Phillips

Publications

Citations

H-Index

Page 1

	Year	Citations
Tenofovir-Based Preexposure Prophylaxis for HIV Infection among African Women Jeanne Marrazzo, Gita Ramjee, Barbra A. Richardson, New England Journal of Medicine	2015	1.3K
Efficacy of Carraguard for prevention of HIV infection in women in South Africa: a randomised, double-blind, placebo-controlled trial Stephanie Skoler-Karpoff, Gita Ramjee, Khatija Ahmed, The Lancet Sexual HealthPreventive MedicineTreatment And PreventionGlobal HealthDisease Prevention	2008	503
Use of a Vaginal Ring Containing Dapivirine for HIV-1 Prevention in Women Jared M. Baeten, Thesla Palanee‐Phillips, Elizabeth R. Brown, Obstetrical & Gynecological Survey GynecologySocial SciencesHiv-1 Infection IncidenceContraceptionHiv/aids Counselling	2016	373
Twice-Yearly Lenacapavir or Daily F/TAF for HIV Prevention in Cisgender Women Linda‐Gail Bekker, Moupali Das, Quarraisha Abdool Karim, New England Journal of Medicine	2024	358
PRO2000 vaginal gel for prevention of HIV-1 infection (Microbicides Development Programme 301): a phase 3, randomised, double-blind, parallel-group trial Sheena McCormack, Gita Ramjee, Anatoli Kamali, The Lancet Sexual HealthParallel-group TrialTreatment And PreventionPro2000 Vaginal GelReproductive Health	2010	333
HIV incidence among women using intramuscular depot medroxyprogesterone acetate, a copper intrauterine device, or a levonorgestrel implant for contraception: a randomised, multicentre, open-label trial Khatija Ahmed, Jared M. Baeten, Mags Beksinska, The Lancet	2019	296
An Empiric HIV Risk Scoring Tool to Predict HIV-1 Acquisition in African Women Jennifer E. Balkus, Elizabeth R. Brown, Thesla Palanee‐Phillips, JAIDS Journal of Acquired Immune Deficiency Syndromes	2016	157
Acceptability and use of a dapivirine vaginal ring in a phase III trial Elizabeth Montgomery, Ariane van der Straten, Miria Chitukuta, AIDS	2017	129
Safety, uptake, and use of a dapivirine vaginal ring for HIV-1 prevention in African women (HOPE): an open-label, extension study Jared M. Baeten, Thesla Palanee‐Phillips, Nyaradzo Mgodi, The Lancet HIV Sexual HealthPreventive MedicineHiv/aids CounsellingTreatment And PreventionAntiviral Therapy	2021	108
Tenofovir 1% vaginal gel for prevention of HIV-1 infection in women in South Africa (FACTS-001): a phase 3, randomised, double-blind, placebo-controlled trial Sinéad Delany‐Moretlwe, Carl Lombard, Deborah Baron, The Lancet Infectious Diseases Sexual HealthPhase 3Treatment And PreventionSouth AfricaAntiviral Therapy	2018	94

Page 1